Stay updated on Long Term Inclisiran in High CV Risk Clinical Trial
Sign up to get notified when there's something new on the Long Term Inclisiran in High CV Risk Clinical Trial page.
Latest updates to the Long Term Inclisiran in High CV Risk Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedMinor revision update from v3.3.3 to v3.3.4 on the page history, with no changes to study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed from the page.SummaryDifference0.2%
- Check58 days agoChange DetectedRevision history now shows a new site release labeled v3.3.2, and v3.2.0 has been removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check65 days agoChange DetectedRemoved the generic operating-status notice about government funding and NIH/OPM status from the page. The core study history details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%
- Check79 days agoChange DetectedBoth old and new screenshots show the same version history for NCT03814187 with no new data or core content changes. Any differences seem to be minor UI adjustments rather than substantive updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check108 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference11%
Stay in the know with updates to Long Term Inclisiran in High CV Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Inclisiran in High CV Risk Clinical Trial page.